Literature DB >> 14126045

TRANQUILLIZING AND HYPOTENSIVE ACTIVITIES OF TWELVE PHENOTHIAZINES.

K P BHARGAVA, O M CHANDRA.   

Abstract

Twelve phenothiazine derivatives have been compared in relation to their central sedative, tranquillizing and hypotensive activities. The ED50's of the compounds to suppress the conditioned response, unconditioned response and forced locomotor activity were determined. Suppressions of the conditioned and unconditioned responses were taken as criteria for tranquillizing and central sedative activities respectively. The "tranquillizing ratio" (ED50 for unconditioned response/ED50 for conditioned response) was used as the criterion of tranquillizing activity in relation to sedative activity and for purposes of comparison this ratio was assigned a value of unity for chlorpromazine. Perphenazine was the most potent drug in suppressing the conditioned and unconditioned responses whereas fluopromazine had the maximal "tranquillizing index" activity. Six compounds had great, three moderate and three mild hypotensive activity when doses of 1 mg/kg were injected intravenously into dogs. The relationship of the chemical structure to the central sedative activity is discussed.

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; CHLORPROMAZINE; DOGS; EXPERIMENTAL LAB STUDY; HYPNOTICS AND SEDATIVES; PERPHENAZINE; PHARMACOLOGY; PHENOTHIAZINES; PROCHLORPERAZINE; THIOPROPERAZINE; THIORIDAZINE; TRANQUILIZING AGENTS; TRIFLUOPERAZINE

Mesh:

Substances:

Year:  1964        PMID: 14126045      PMCID: PMC1703905          DOI: 10.1111/j.1476-5381.1964.tb01553.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  15 in total

1.  [Pharmacological comparison of chlorpromazine and mellaril, 3-methyl-mercapto-10-[2-(N-methyl-2-piperdvl)-ethyl]-phenothiazine hydrochloride].

Authors:  T J HALEY; A M FLESHER; K RAYMOND
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-03-01

2.  Differential analysis of the effects of phenothiazine-tranquillizers on emotional and motor behavior in experimental animals.

Authors:  M TAESCHLER; A CERLETTI
Journal:  Nature       Date:  1959-09-12       Impact factor: 49.962

3.  Correlation in rats between the locomotor and avoidance suppressant potencies of eight phenothiazine tranquilizers.

Authors:  S IRWIN
Journal:  Arch Int Pharmacodyn Ther       Date:  1961-07-01

4.  Tranquillizers.

Authors:  M W PARKES
Journal:  Prog Med Chem       Date:  1961

5.  A comparative quantitative study of the central depressant effect of seven clinically used phenothiazine derivatives.

Authors:  F SANDBERG
Journal:  Arzneimittelforschung       Date:  1959-04

6.  Pharmacological and acute toxicological comparisons of triflupromazine and chlorpromazine.

Authors:  J J PIALA; J P HIGH; G L HASSERT; J C BURKE; B N CRAVER
Journal:  J Pharmacol Exp Ther       Date:  1959-09       Impact factor: 4.030

7.  Behavioral effects of some psychopharmacological agents.

Authors:  L COOK; E WEIDLEY
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

8.  Experimental studies with chlorpromazine; effect on cerebrospinal fluid pressure, blood pressure, respiration and pial vessel diameter in the cat.

Authors:  S FELDMAN; D P KIDRON
Journal:  Arch Int Pharmacodyn Ther       Date:  1957-06-01

9.  Perphenazine (trilafon), a new potent tranquilzer and antiemetic. I. Behavioral mode of action.

Authors:  S IRWIN; M SLABOK; P L DEBIASE; W M GOVIER
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-02-01

10.  ANTI-EMETIC ACTIVITY OF PHENOTHIAZINES IN RELATION TO THEIR CHEMICAL STRUCTURE.

Authors:  K P BHARGAVA; O CHANDRA
Journal:  Br J Pharmacol Chemother       Date:  1963-12
View more
  1 in total

1.  Inhibition of Ca2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats.

Authors:  Masafumi Shirahama; Soichiro Ushio; Nobuaki Egashira; Shota Yamamoto; Hikaru Sada; Ken Masuguchi; Takehiro Kawashiri; Ryozo Oishi
Journal:  Mol Pain       Date:  2012-04-17       Impact factor: 3.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.